Siaton, Nimfa .

HRN: 18-65-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/17/2023
03/24/2023
IV
500mg
Q8
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 
03/17/2023
CEFUROXIME 1.5GM (VIAL)
03/17/2023
03/19/2023
IVTT
1.5g
Q8h X 7 More Doses
Postop
Waiting Final Action 
03/18/2023
CEFUROXIME 500MG (TAB)
03/18/2023
03/25/2023
ORAL
500mg
BID
S/P LTCS
Waiting Final Action 
03/18/2023
METRONIDAZOLE 500MG (TAB)
03/18/2023
03/25/2023
ORAL
500mg
TID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: